Menu
Not yet recruiting NCT07667179

NAVO:J School-Based Group Intervention for Adolescent Mental Health

No phase Interventional Resilience Depression

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: NAVO:J (digital mental health platform).
Who it may be relevant to
Registry conditions: Resilience, Depression. Basic parameters: 7 years — 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of a School-Based Group Intervention Using the Digital Mental Health Platform NAVO:J on Adolescent Mental Health

Overview

The purpose of this study is to determine and verify whether a school-based group intervention using the digital mental health platform NAVO:J can effectively improve the mental health of adolescents-particularly reducing depression, anxiety, and stress while enhancing resilience.

Detailed description

NAVO:J is a digital mental health platform designed to promote adolescent mental health.

The intervention will be conducted as a single-group pre-post design with students (N = 250 subjects) who apply for the Level 2-2 (group intervention) program.

The intervention period will be 17 weeks (17 sessions, once a week for about 40 minutes), with a mid-point evaluation at week 8 and a post-intervention evaluation at week 17.

Interventions

  • Behavioral NAVO:J (digital mental health platform)
    Participants use NAVO:J, a digital mental health platform developed for adolescents, delivered as a structured group intervention over 17 weeks (17 sessions, once weekly, approximately 40 minutes each). The platform provides algorithm-based recommended videos, 12 tailored "mind solutions" based on emotional-behavioral characteristics, self-assessments (personality, depression, anxiety, stress, self-esteem, smartphone use), expert-supported community features, mind coaching, growth tracking acros

Primary outcome measures

  • Change in Depression (PHQ-9) [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Resilience (CD-RISC-10) [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
Secondary outcome measures (8)
  • Change in Maum-EASY Anxiety and Depression Problems [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Maum-EASY Suicide and Crisis Problems [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Maum-EASY Externalizing Problems [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Maum-EASY Psychological Trauma Problems [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Maum-EASY School Life Adjustment [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Subjective Mental Health (VAS) [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Empathy Quotient (K-EQ) [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]
  • Change in Grit (GRIT-S) [Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)]

Eligibility criteria

Inclusion criteria

  • Students who apply for the group intervention program
  • Possession of an internet-enabled smartphone
  • Consent to study participation by both the participant and their legal guardian

Exclusion criteria

  • Inability to install or run "NAVO:J" on the participant's smartphone
  • Current participation in another interventional study
  • A medical condition severe enough to preclude the intervention or outcome assessment
  • Judged by the researcher to be unlikely to participate cooperatively through the end of the study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

South Korea · 1 center
  • Ajou Medical University — Suwon

Identifiers

NCT: NCT07667179 · AJOUIRB-IV-2026-290

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗